We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

011070:KRXLG Innotek Co., Ltd Analysis

Data as of 2026-06-21 - not real-time

₩1,145,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

LG Innotek is trading at KRW 1,145,000, comfortably above its 20‑day (KRW 1,153,600), 50‑day (KRW 788,760) and 200‑day (KRW 380,274) moving averages, signaling a bullish price placement. However, the MACD has turned bearish (histogram –18,035) and the RSI sits at a neutral 55.96, while volume is on a decreasing trend and 30‑day volatility spikes at 141%, indicating heightened short‑term risk. The stock’s forward P/E of 27.9 is below the industry average of 38.1, yet the DCF‑derived fair value of KRW 211,543 suggests the market price is overvalued by more than 20%, compounded by a beta of 1.07 and a max drawdown of –32%.
Fundamentally, the company posted 11% revenue growth with modest margins (gross 8.6%, operating 5.3%, profit 2.2%) and strong cash generation (operating cash flow KRW 1.33T). Debt‑to‑equity is high at 36.1, but the dividend payout is low (9% of earnings) with a sustainable yield of 0.16%. The “Extreme Greed” sentiment (fear‑greed index 91.5) and a robust market cap offset some concerns, but the combination of high volatility, decreasing volume, and overvaluation drives a cautious outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD divergence
  • Overvalued DCF gap
  • Decreasing volume and high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • 11% revenue growth and solid cash flow
  • Moderate forward P/E relative to industry
  • Sustainable dividend despite low yield

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Exposure to automotive, IoT and EV supply chains
  • Strong balance sheet with ample cash
  • Potential upside from sector tailwinds outweighing current overvaluation

Key Metrics & Analysis

Financial Health

Revenue Growth11.10%
Profit Margin2.16%
P/E Ratio27.9
ROE8.46%
ROA4.60%
Debt/Equity36.13
Op. Cash Flow₩1331.1B
Free Cash Flow₩277.6B
Industry P/E38.1

Technical Analysis

TrendBullish
RSI56.0
Support₩769,000.00
Resistance₩1,788,000.00
MA 20₩1,153,600.00
MA 50₩788,760.00
MA 200₩380,273.50
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value₩211,543.40
Target Price₩888,653.90
Upside/Downside-22.39%
GradeOvervalued
TypeBlend
Dividend Yield0.16%

Risk Assessment

Beta1.07
Volatility141.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.